1847P Professional standing of young medical oncologists in Spain during COVID-19 pandemic: A nationwide survey by the Spanish Society of Medical Oncology (SEOM) +MIR Section
Year: 2021
Type: article
Study design: Observational Study
Source: Annals of Oncology
Institutions: Hospital Central de la Defensa Gómez Ulla, Hospital Universitario Virgen de la Arrixaca, Hospital Universitario Infanta Leonor, Hospital Can Misses, Hospital Clínico Universitario Lozano Blesa, Hospital de Cruces, Hospital de Sant Pau, Hospital General Universitario de Elche, Hospital General Universitario Morales Meseguer, Hospital Clínico Universitario de Valencia, Complejo Hospitalario de Ourense, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology
Language: English
Subfield: Gender Studies
Field: Social Sciences
Domain: Social Sciences
Open Access status: bronze
Funders: Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, F. Hoffmann-La Roche, Array BioPharma, Regeneron Pharmaceuticals, Les Laboratories Pierre Fabre, Mylan, BeiGene, Advanced Accelerator Applications, Eisai, Angelini Pharma, European Society for Medical Oncology, Sociedad Española de Oncología Médica, Servier, Centro de Investigación Biomédica en Red de Cáncer, Ipsen, Grifols, LEO Pharma
Award: G3939107412
OpenAlex ID: W3203772829
